ALBERT

Description / Table of Contents: Preface -- A Brief History of Immunological Research into Psychosis and Pathways for Immune Influence of the Brain.-Basic Concept of Microglia Biology and Neuroinflammation in Relation to Psychiatry -- Epidemiological Studies of Prenatal and Childhood Infection and Schizophrenia -- Schizophrenia, Cytokines and Other Systemic Inflammatory Mediators [to include oxidative stress and lymphocyte alterations] -- Association between Schizophrenia, Microbial Infection and Microbiota -- Autoantibodies and psychosis -- Effect of Infection on Cognition in Schizophrenia and Healthy People -- Role of Infection, Autoimmunity, Atopic Disorders and the Immune System in Schizophrenia: Evidence from Epidemiological and Genetic Studies -- Microglial Activation and Psychotic Disorders: Evidence from Pre-clinical and Clinical Studies -- Early-Life Adversity, Systemic Inflammation, and Co-Morbid Physical and Psychiatric Illnesses of Adult Life -- Inflammation, Antipsychotic Drugs and Evidence for Effectiveness of Anti-inflammatory Agents in Schizophrenia.

Description / Table of Contents: The Architecture of the Presynaptic Release Site.-Cytomatrix Proteins in Presynaptic Terminal. - Multiple Modes of Fusion and Retrieval at the Calyx of Held Synapse -- Roles of SNARE Proteins in Synaptic Vesicle Fusion -- Calcium Sensors of Neurotransmitter Release. - Roles and Sources of Calcium in Synaptic Exocytosis -- Regulation of Presynaptic Calcium Channels -- Roles of mUnc13/UNC-13 and mUnc18/UNC-18 in Neurotransmitter Release. - The role of tomosyn in the regulation of neurotransmitter exocytosis. -Roles of complexins in Neurotransmitter Release. -Regulation of Neurotransmitter Release by AIPR-1/AIP and calstabins. - The Role of Potassium Channels in the Regulation of Neurotransmitter Release -- Roles of Neuropeptides in Synaptic Function. - Transsynaptic Regulation of Presynaptic Release Machinery in Central Synapses by Cell Adhesion Molecules. - Lipids and Secretory Vesicle Exocytosis -- Synaptic Vesicle Endocytosis.

Description / Table of Contents: Introduction -- Rodent Taxonomic and biological data -- Basic Neurohistology -- Basic Neuroanatomy/ Coverings of the CNS/ Cerebrospinal fluid system -- Microscopic anatomy of the mouse brain -- The mouse spinal cord -- The mouse brainstem -- The mouse cerebellum -- The mouse dorsal thalamus -- The mouse hypothalamus.-The mouse cerebral cortex.-The mouse hippocampus.-The mouse amygdala -- The mouse caudate putamen -- The mouse oflactory system -- The mouse circle of Willis.

Description / Table of Contents: 1 Rodent Stroke Model Guidelines: An Update -- 2 Bilateral Common Carotid Artery Occlusion: Stroke Model -- 3 Cerebral Venous Sinus Thrombosis Rodent Model -- 4 A Non- Human Primate Model for Cerebral Stroke -- 5 Laser Doppler Flowmetry Recording for Rodent Stroke Model Confirmation -- 6 Laser Speckle Imaging for Cerebral Ischemia and Reperfusion Injury -- 7 Cerebrovascular imaging in a rodent stroke model -- 8 Photothrombotic stroke model. .

Description / Table of Contents: Overview chapter -- Imaging studies linking dopaminergic systems to impulsivity in humans -- The Genetics of Externalizing Problems -- The neuropharmacology of impulsive behaviour: ten years later -- Inhibitory control and impulsivity in childhood onset disruptive behavior disorders -- Steep discounting of future rewards as an impulsivity phenotype: a concise review -- Developmental considerations in impulsivity: Implications for research and treatment -- Reinforcer Pathology: Implications for Substance Abuse Intervention -- Impulsivity and Suicidal Behavior -- Sex differences in neural circuits underlying inhibitory control -- The role of impulsivity facets on the incidence and development of alcohol use disorders -- The neurobiology of reinforcement learning mechanisms in impulsivity.

Description / Table of Contents: Overview of the Human Brain and Spinal Cord -- Vascularization of the Brain and Spinal Cord -- Notes on Techniques -- The Somatosensory System -- The Reticular Formation and the Neuromodulatory Systems -- The Cranial Nerves -- The Auditory System -- The Visual System -- Motor Systems -- The Cerebellum -- The Basal Ganglia -- The Autonomic Nervous System -- The Hypothalamus, the Preoptic Area and Hypothalamohypophysial Systems -- The Limbic System -- The Cerebral Cortex and Complex Cerebral Functions.

Description / Table of Contents: Part 1: Mechanisms underlying brain changes during sensitive periods -- Development of functional properties in the early visual system: new appreciations of the roles of lateral geniculate nucleus -- Maturation of Corticolimbic Functional Connectivity during Sensitive Periods of Brain Development -- Microglia and sensitive periods in brain development -- Is Adolescence a Sensitive Period for the Development of Incentive Reward Motivation? Part 2: The influences of positive and negative factors during sensitive periods -- Physical Activity, Fitness and Executive Functions in Youth: Effects, Moderators and Mechanisms -- Nutrition and brain development.-Understanding sensitive period effects in musical training -- Sensitive periods for recovery from early brain injury -- Part 3: Community level impact of sensitive periods: analyses and applications -- Statistical Modeling of Sensitive Period Effects Using the Structured Life Course Modeling Approach (SLCMA) -- Capitalizing on neuroplasticity across development to redirect pathways from juvenile justice involvement.

Description / Table of Contents: 1. Ayahuasca as an Unusually Versatile Therapeutic Agent: From Molecules to Meta-cognition and Back -- 2. New Evidence of the Antidepressant Effects of Ayahuasca -- 3. Psychedelic Medicines and Their Role in Shifting the Paradigm from Pharmacological Substitution Towards Transformation-Based Psychiatry -- 4. Ayahuasca and its Potential Role in Psychotherapy -- 5. A Qualitative Assessment of Risks and Benefits of Ayahuasca for Trauma Survivors -- 6. Ayahuasca and Childhood Trauma: Potential Therapeutic Applications and Risks -- 7. Ayahuasca and Cognition -- 8. Healing with the Brew: Ayahuasca’s Reconfiguration of “Addiction” -- 9. Ayahuasca Ritual Healing as an Addiction Treatment in Catalonia: Combining Cognitive and Cultural Perspectives -- 10. Perspectives on Healing and Recovery from Addiction with Ayahuasca-Assisted Therapy Among Members of an Indigenous Community in Canada -- 11. Ayahuasca as a Healing Tool Along the Continuum of Recovery from Eating Disorders -- 12. The Therapeutic Use of Ayahuasca in Grief -- 13.Depression, Anxiety and Sorcery: An Interview with Shipibo Healer Jose Lopez.

Description / Table of Contents: PART I. Basic -- Spinal Cord Injury -- Functional Electrical Stimulation -- Electroencephalography & Brain-Computer Interfaces -- PART II. Neuroprosthetics in SCI -- History of Neuroprosthetics -- Upper Extremity Neuroprosthetics for Spinal Cord Injury -- Neuro-Robotics: Rehabilitation and Restoration of Walking using Exoskeletons via Non-invasive Brain Machine Interfaces -- Epidural and Transcutaneous Spinal Cord Stimulation Strategies for Motor Recovery after Spinal Cord Injury -- PART III. Clinical Brain-Computer Interfaces -- P300 BCI for Persons with Spinal Cord Injury – a BCI in Search of an Application? -- Invasive BCI Approaches for Restoration of Upper Extremity Movements -- Towards Non-invasive BCI Based Movement Decoding -- PART IV. Clinical Use Cases and Practice -- Therapeutic Applications of Electrical Stimulation in Spinal Cord Injury -- Brain Computer Interface Controlled Functional Electrical Stimulation for Rehabilitation of Hand Function in People with Spinal Cord Injury -- Non-invasive Brain-Computer Interfaces for Control of Grasp Neuroprosthesis - The European MoreGrasp Initiative -- PART V. Outlook -- Therapies of the Future.

Description / Table of Contents: PART I - Introduction -- Innovator, Entrepreneur, Leader: The Tripartite Drug Discovery Neuroscientist -- PART II - Innovation in the Discovery of Novel Therapeutic Approaches -- Drug Discovery in CNS: Finding a Target for What? -- Neurogenomics with Application to Schizophrenia and Other Major Neuropsychiatric Diseases with Complex Heredity -- Epigenetics in Drug Discovery: Achievements and Challenges -- Conventional Behavioral Models and Readouts in Drug Discovery: The Importance of Improving Translation -- Safety and Drug Metabolism: Toward NCE and First in Human -- The Various Forms of Non-invasive Brain Stimulation and Their Clinical Relevance -- Is Non-invasive Brain Stimulation the Low-Hanging Fruit? -- PART III - Translational Medicine and Technology -- Electrophysiology: From Molecule to Cognition, from Animal to Human -- MRI in CNS Drug Development -- Positron Emission Tomography in Drug Development -- Application of Cognitive Test Outcomes for Clinical Drug Development -- Exciting Research in the Field of Sexual Psychopharmacology: Treating Patients with Inside Information -- A Paradigm Shift from DSM-5 to Research Domain Criteria: Application to Translational CNS Drug Development -- PART IV - Clinical Development and Regulatory Approval -- The Special Challenges of Developing CNS Drugs -- Phase 1 Clinical Trials in Psychopharmacology -- Early Development of Erenumab for Migraine Prophylaxis -- Microdosing Psychedelics as a Promising New Pharmacotherapeutic -- Partnering with the FDA.

Description / Table of Contents: Gut Microbiome Brain Axis: An Introduction -- Cross talk between gut microbiota and host immune cells -- Microbiota-Gut-Brain Axis and Neurodegenerative Disorder -- Gut Microbiota Regulation of Cerebral Stroke -- Aging: Impact of Gut Microbiota -- Gut Microbiome Regulation of Appetite and Neurological Disorders -- Human diets, Gut microbiome and Neuroinflammation -- Dietary Fatty acids, Gut microbiome and Gut-Brain communication: A Current perspective -- Role of Short Chain Fatty Acids from Gut Microbiota in Neuroendocrine Pathogenesis Management -- Potential role of probiotics on gut microbiota in neurological disease -- Reversal of metabolic disorder through the restoration of gut microbiota -- Gut Microbiome and Diet: Promising Approach for Treatment of Cognitive Impairment -- Nanoplastics, Gut microbiota and Neurodegeneration -- Gut Microbiome, COVID-19, and Neurological Impairment -- Tools to study Gut Microbiome -- Germ-Free Mice Technology: opportunity for Future Research -- Gut Microbiome and Neurodegeneration: A Bioinformatics Approach.

Description / Table of Contents: Part 1: Neurological disorders from Background to interplay of Genetic, Epigenetic and Environmental risk factors -- Chapter 1: Phytonutrients in Neurological Disorders -- Chapter 2: Psychobiotics in health, longevity and neurological disorders -- Chapter 3: Nutritional, dietary, and lifestyle approaches for prevention and management of Alzheimer’s disease.-Chapter 4: Qualitative and Analytical Treatment of Nonlinear Dynamical systems in Neurological Diseases -- Chapter 5: Impact of a psychological follow-up of diabetics in the management of diabetes in Morocco -- Chapter 6: Neuroprotective and anxiolytic effects of date seeds phenolic compounds in Nicotinamide-Streptozotocin-Induced type 2 diabetic rats -- Chapter 7: Role of nutrition in pathogenesis of neurological disorders -- Part 2: Specific Food and Nutritional Qualities on Neruological Disorders -- Chapter 8: Best foods for repair of brain damage -- Chapter 9: Role of micronutrients in neurological development -- Chapter 10: Algae as a potential vegetative source of PUFA for the prevention of neurological disorders -- Chapter 11: Natural foods for suppressing Dementia -- Chapter 12: Nutrients' role in the treatment of Parkinson's and Alzheimer's diseases -- Chapter 13: Novel marine derived natural products for the treatment of depressive disorder -- Chapter 14: Nanoceuticals as Theranostics against Neurodegenerative diseases -- Chapter 15: Role of Antioxidant Nutraceuticals in Neurodegenerative diseases -- Part 3: Herbal remedies for Neurological disorders -- Chapter 16: Herbal drugs: Its molecular mechanism to prevent Alzheimer’s disease with special reference to non-phenolic secondary metabolites -- Chapter 17: Preventive Role And Mechanism Of Herbal Medicine In Alzheimer’s Disease With Special Reference To Phenolic Compounds -- Chapter 18: Herbal Remedies for Autism -- Chapter 19: Action of herbal products in suppressing Parkinson’s Disorder -- Chapter 20: Impact of diet on neurotransmitters.

Description / Table of Contents: (R)-ketamine: A new rapid-acting antidepressant -- (2R,6R)-hydroxynorketamine, a metabolite of ketamine: the antidepressant actions and the mechanisms -- Predictable biomarkers for rapid-acting antidepressant response to ketamine -- Nitrous Oxide: an old compound with emerging psychotropic properties -- Novel AMPA receptor potentiators TAK-137 and TAK-653 as potential rapid-acting antidepressants -- AMPA receptor potentiators as potential rapid-acting antidepressants -- mGlu2/3 receptor antagonists as rapid-acting antidepressants -- Antidepressant effects of the muscarinic receptor antagonist scopolamine: Clinical and preclinical review.

Description / Table of Contents: 1. Introduction -- 2. Diversity and evolution of jellyfish visual systems, Mollusks -- 3. Scallops distributed eyes -- 4. Chiton dispersed visual systems, Annelids -- 5. Errant polychaetes Arthropods -- 6. Spider eyes -- 7. Myriapod eyes -- 8. Insect ocelli -- 9. Batflies, copepods or larval stomatopods -- 10 -- Hyperiid amphipods, Echinoderms -- 11. Brittle star vision -- 12. Starfish vision.

Description / Table of Contents: Chapter. 1. Introduction -- Chapter. 2. Eusociality -- Chapter. 3. Brain and social environment -- Chapter. 4. Socio-biological interactions -- Chapter. 5. Social Inequality -- Chapter. 6. Culture and evolution -- Chapter. 7. Means of social coercion -- Chapter. 8. Population growth and the collective brain -- Chapter. 9. Tooling and technology -- Chapter. 10. The Homo sapiens, evolution of the warmonger human -- Chapter. 11. Factors of our human future -- Chapter. 12. On the human dimension -- Chapter. 13. Our species’ hypothetical alternatives.

Description / Table of Contents: Editorial -- Dystonia in childhood - how insights from paediatric research enrich the network theory of dystonia -- Focal Dystonia and the Stress-Network -- Limbic influences in Musicians dystonia -- Network perspective on task-specific dystonia -- Electromyography as a method for distinguising dystonia-like behavior in mice -- Deep brain stimulation of the interposed cerebellar nuclei in a mouse model of dystonia -- Applications of Transcranial Magnetic Stimulation for understanding and treating dystonia -- Brain connectivity in dystonia: evidence from Magnetoencephalography -- Dysfunctional networks in functional dystonia -- Collicular-pulvinar-amygdala axis and adult-onset idiopathic focal dystonia syndrome -- Neuromodulation in dystonia -- Electrophysiological properties of pallidal cells in cervical dystonia patients undergoing unilateral DBS -- Clinical implications of dystonia as a neural network disorder.

Description / Table of Contents: Chapter 1. Introduction -- Chapter 2. Noise and Randomness in Science and Engineering -- Chapter 3. Various Types of Noise and their Sources -- Chapter 4. Constructive Role of Noise and Nonlinear Dynamics -- Chapter 5. Noise and Synchronization of Oscillatory Networks -- Chapter 6. Stochastic Fluctuations at Cellular and Molecular level -- Chapter 7. Various Types of Noise and their Sources in Living Organisms -- Chapter 8. Ion Channel Noise in Biological Systems -- Chapter 9. Noise in Cellular Communication -- Chapter 10. The Role of Noise in Brain Function -- Chapter 11. Noise and Gene Oscillators -- Chapter 12. Developmental Noise and Stability -- Chapter 13. Noise and Coherence in Meditation -- Chapter 14. Chaos, Stochasticity and Noise -- Chapter 15. Chance, Determinism and Laws of Nature.

Description / Table of Contents: Chapter 1. An Unsolved Problem in Gerontology Yet : The Molecular Mechanism of Biological Aging – A Historical and Critical Overview -- Chapter 2. Clinical and Basic Biology of Werner Syndrome, the Model Disease of Human Aging -- Chapter 3. Biomarkers of Healthy Longevity: Lessons from Supercentenarians in Japan -- Chapter 4. Cellular aging and metabolites in aging -- Chapter 5. To G0 or Not to G0: Cell Cycle Paradox in Senescence and Brain Aging -- Chapter 6. C. elegans longevity genes -- Chapter 7. Understanding the functions of longevity genes in Drosophila -- Chapter 8. NAD+ metabolism in Aging -- Chapter 9. Mitochondrial dysfunction and growth differentiation factor 15 in aging -- Chapter 10. Sirtuins and metabolic health -- Chapter 11. Autophagy in aging and longevity -- Chapter 12. Sarcopenia: current topics and future perspective -- Chapter 13. Osteoporosis and cellular senescence in bone -- Chapter 14. Aging and chronic kidney disease viewed from the FGF-Klotho endocrine system -- Chapter 15. Aging biomarker SMP30 into a new phase of vitamin C and aging research -- Chapter 16. Age-related memory impairments are caused by alterations in glial activity at old ages -- Chapter 17. Critical Roles of Glial Neuroinflammation in Age-Related Memory Decline -- Chapter 18. Central mechanisms linking age-associated physiological changes to healthspan through the hypothalamus -- Chapter 19. PET imaging of amyloid and tau in Alzheimer’s disease -- Chapter 20. Presenilin/γ-secretase in the pathogenesis of Alzheimer disease -- Chapter 21. Amyloid-β in brain aging and Alzheimer’s disease -- Chapter 22. Tau Pathology and Neurodegenerative Disorders -- Chapter 23. Aging and Parkinson’s disease: pathological insight on model mice -- Chapter 24. Evaluating the brain aging through eyes: The Potential use of hyperspectral imaging cameras to diagnose Alzheimer's disease risk -- Chapter 25. Healthy Aging in Japan.

Description / Table of Contents: Chapter 1. Introduction -- Chapter 2. The Psychiatrist and Pathologist Aloysius Alzheimer and His Seminal Findings -- Chapter 3. Alzheimer’s Disease Research After 1945: The Recommencement -- Chapter 4. Alzheimer’s Research Goes Deeper – Ultrastructural Electron Microscopy Studies -- Chapter 5. Focus on Neurochemistry Led to the Cholinergic Hypothesis of Alzheimer’s Disease -- Chapter 6. The Glutamatergic-Hypothesis of Alzheimer’s Disease -- Chapter 7. Biochemistry and Genetics Points Out a Prime Suspect for Causing Alzheimer’s Disease -- Chapter 8. Getting to the Bottom of It: Amyloid Beta Peptide Is Derived from a Larger Precursor -- Chapter 9. Step by Step Towards an Amyloid Beta Peptide-Based Hypothesis of Alzheimer’s Disease -- Chapter 10. Concerns about the Amyloid Cascade Hypothesis and Reappraisals -- Chapter 11. Ignorance or Conspiracy? Or Just an Amyloid Firewall that Blocks Alternative Ideas? -- Chapter 12. In the Slip Stream of Amyloid: The Tau and Tangle Hypothesis -- Chapter 13. Focus on Tauopathies and Beyond -- Chapter 14. Alzheimer’s Research Gains Momentum and Spreads Out -- Chapter 15. The Amyloid Cascade Hypothesis Has to Deliver, Finally -- Chapter 16. Beyond APP, PSEN1, PSEN2, and APOE: What Else Does the Genome Tell Us? Chapter 17. Alternative Hypotheses and Observations that were Somehow Lost on the Way -- Chapter 18. Is the Persistence of the Amyloid Cascade Hypothesis a Result of Constant Confirmation Bias? -- Chapter 19. Driving Forces of Alzheimer’s Research Directions -- Chapter 20. Thirty Years after the Launch of the Amyloid Cascade Hypothesis: Is There a Shift of Gears at Last? -- Chapter 21. "If You Change the Way You Look at Things, Things You Look at Change".

Description / Table of Contents: High Resolution Imaging Mass Spectrometry of Human Donor Eye: Photoreceptor Cells and Basal Laminar Deposits of Age-related Macular Degeneration -- The non-canonical role of Complement Factor H in Retinal Pigment Epithelium (RPE) cells and implications for Age-related Macular Degeneration -- Macular Pigment Carotenoids and Bisretinoid A2E -- Disturbed matrix metalloproteinases activity in age-related macular degeneraton -- Current views on Chr10q26 contribuiton to age-related macular degeneration -- Untargeted lipidomic profiling of aged human retina with and without age-related macular degeneration (AMD) -- Decoding Race and Age-Relation Macular Degeneration: GPR 143 Activity is the Key -- Peroxisome proliferator-activated receptor gamma coactivator 1 alpha ( PGC-1x): a transcriptional regulator at the interface of aging and age-related macular degeneration? -- Regulation of ABCA1 by miR-33 and miR-34a in the aging eye -- The role of gene expression regulation on genetic risk of Age-related Macular Degeneration -- Elastin layer in Bruch's membrane as a target for immunizatio or tolerization to modulate patthology in the mouse model of somke-induced ocular injury -- Repuprosing drugs for treatment of age-relation macular degeneration -- Extracellular Vesicle RNA Contents as Biomarkers for Ocular Diseases -- Proteomics of retinal extracellular vesicles: a reviw inot an unexplored mechanism in retinal health and AMD pathogenesis -- Prime Editing Strategy to Instally the PRHP2 c.828+1G A mutations -- Analysis of CRB1 Pathogenic Variants Correctable with CRISPR Base and Prime Editing -- Generation of an Avian Myeloblastosis Virus (AMV) Reverse Transcriptase Prime Editor -- Pre-existing neutralizing antibodies against different adeno-associated virus serotypes in humans and large animal models for gene therapy -- Optimization of Capillary-based Western Blotting for MYO7A -- AAV Serotypes and Their Suitability for Retinal Gene Therapy -- Gene Augmentation ofautosomal dominant CRX-associated retinopathies -- Txnip gene therapy of retinitis pigmentosa improves cone health Factors affecting readthrough of natural versus premature termination codons -- Integrating Computational Approaches to Predict the Effect of Genetic Variants on Protein Stability in Retinal Degenerative Disease -- Network biology and medcine to resuce: Applications for retinal disease mechanisms and therapy -- Non-sydromic Retinal Degeneration Caused by Pathogenic Variants in Joubert Syndrome Genes -- Exonic variants that affect splicing- an opportunity for "hidden" mutations causing inherited retinal diseases -- Enhanced S-cone Syndrome, a Mini-Review -- The role of microglia in Inherited Retinal Diseases -- CD68: potential contributor to inflammation and RPE cell dystrophy -- Gene Expression of Clusterin, Tissue Inhibitor of Metalloproteinase-1, and Their receptors in Retinal Pigment Epithelial Cells and Muller Glial Cells is Modulated by Inflammatory Stresses -- Axonal Transport Defects in Retinal Ganglion Cells -- Connexins biology in the pathophysiology of retinal diseases -- Role of Nuclear NAD +in Retinal Homeostasis -- Retinal pigmented epithelium-derived ectopic norrin does not promote intraretinal angiogenesis in transgenic mice -- Caveolin-1 Muller glia exist as heat-resistant,high molecular weight complexes -- Role of VLC-PUFAs in Retinal and Macular Degeneration -- Ocular amyloid , condensates, and aggregates - higher order protein assemblies participate in both retinal degeneration and function -- Photoreceptor ion channels in signaling and disease -- The role of peripherin-2 /ROM1 complexes in photoreceptor outer segment disc morphogenesis -- Human mutations in Arl3, a small GTPase involved inlipidated cargo delibery to the cilia cause retinatl dystropthy -- Genotype-Phenotype Association in ABCA4-Associated Retinopathy -- Retinal pathoconnectomics: A Window into Neurodegeneration -- The role of Ceramide in Inherited Retinal Disease Pathology -- Extracelluar Matix: the Unexplored Aspects of Retinal Pathologies and Regeneration -- Role of TFEB in diseases assocaited with lysosomal dysfunction -- Retinoic acid receptor -related oprhan receptors (RORs) in eye development and disease -- A novel mouse model for Late-Onset Retinal Degeneration (L-ORD) devekios RPE abnormalities due to the loss of C1qtnf5/Ctrp5 -- Comparison of mouse models of autosomal dominant retinitis pigmentosa due to P23H muations of Rhodopsin -- Compensatory Cone-Mediated Mechanisms in Inherited Retinal Degeneration Mouse Models: A Functional and Gene Expression Analsyis -- Inhibition of Ryanodine Receptor 1 Reduces Endoplasmic Reticulum (ER) Sress and Promotes ER Protein Degradation in Cyclic Nucleotide-gated Channel Deficiency -- Mouse choroid proteome revisited: foucs on aging -- Morphological and functional comparison of mice models for retinitis pigmentosa -- Current Advancements in Mouse Models of Retinal Disease -- Single-cell Itrnacriptomic Profiling of Muller Glia in the rd10 Retina -- Methods for in vivo characterization of proteostatis in the mouse retina -- Absence or PRCD leads to dysregulation in lipie Homeostatis resulting in disorganizationof photorecptor outer segment structure -- Expansion Microscopy of Mouse Photoreceptro Cilia -- Rod photorecptor specific ablation of Metformin target, AMPK, in preclinical model of autosomal recessvie retinitis pigmentosa -- TLR2 is highly overexpressed in retinal myeloid cells in the rd10 mouse model of retinitis pigmentosa -- Environmental light has an essentail effrect on the diseasae expression in a dominant RPE65 mutation -- Microglia Preserve Visual Function in A Mouse Model of Retinitis Pigmentosa with Rhodopsin-P23H Mutant -- Measuring the release of lactate from wild-type and rd1 mouse retina -- Aerobic glycolysis in photorecptors supports energy demand in the absence of mitochondrial coupling -- Redox Status in Retinitis Pigmentosa -- Perspectives on retinal dolichol metabolism and visual deficits in dolichol metalbolism-associated inherited disorders -- Retinal metabolic profile on IMPG2 deficiency mice with subretinal lesions -- Glutathione-coating of liposomes enhances the delivery of hydrophillic cargo to the inner nuclear layer in retinal cultures -- Modification of Mueller glial cell fate and proliferation with the use of small molecules -- A potential neuroprotective role for pyruvate kinase 2 in retinal degeneration -- Critical role of VEGF as a direct regulator of photorecptor function -- Lysine Ubiquitylation Drives Rhodopsin Protein Turnover -- In-silico prediction of MYO!C Rhodopsin Interactions and its Significance in Protein Localization and Visual Function -- A ciliary branched actin netowrk drives photoreceptor disc morphogenesis -- Revisiting the daily timing of POS phagocytosis -- Inhibition of Bacterial Peoptidoglycan Cytopahty by Retina Pigment Epithelial PGRP2 Amidase -- Understanding ischemic retinopathies: the role of Succinate and its recpto^T mutation -- Inducing neural regeneratio nfrom glia using proneural bHLH transcription factors.

Description / Table of Contents: The world of Brain: from Aging Brain, Diseased Brain to Social Brain -- Cognitive Aging：How the Brain Ages -- Cognitive Decline Associated with Aging -- The Overview of Cognitive Aging Model -- The Emotional and Affective Disorders in Cognitive Aging -- The Mechanism of Socioeconomic Status and Stress Effects on Cognition -- The Aging Patterns of Brain Structure, Function and Energy Metabolism -- Characteristics of Brain Network during Cognitive Aging -- Biomolecular Markers of Brain Aging -- Neurobiological Mechanisms of Cognitive Decline Caused by Brain Aging -- The Early Stage of Abnormal Aging: Cognitive Impairment -- The Terminal Stage of Abnormal Aging: Dementia -- The Effect of Cognitive Rehabilitation Training and Its Neuroimaging and Physiology Evidence -- Lifestyle Regulation and Its Evidence: Changes brought from Adjusting Correlative Factors of Cognitive Aging -- The Effect of Traditional Chinese Medicine on Delaying Age-related Cognitive Decline and Its Evidence.

Description / Table of Contents: PART I. Structural Components of the Neuroendocrine Systems -- Chapter 1. Ontogenesis of Hypothalamic Neurons in Mammals -- Chapter 2. Advances in MRI-Based Anatomy of the Human Hypothalamus and Effects of the Hypothalamic Neuropeptide Oxytocin on Brain BOLD Signals -- Chapter 3. Generation of Hypothalamus and Adenohypophysis from Human Pluripotent Stem Cells -- Chapter 4. The Neurohypophysis and Urophysis - Ancient Piscine Neurovascular Interfaces -- Chapter 5. Cytoskeletal Organization and Plasticity in Magnocellular Neurons -- PART II. Neuroanatomy of Hypothalamo-hypophyseal Systems -- Chapter 6. Neuroanatomical and Functional Relationship Between Parvocellular and Magnocellular Oxytocin and Vasopressin Neurons -- Chapter 7. Fine Chemo-Anatomy of Hypothalamic Magnocellular Vasopressinergic System with an Emphasis on Ascending Connections for Behavioural Adaptation -- Chapter 8. Neuroanatomy of the GnRH/Kisspeptin System -- Chapter 9. Corticotropin-Releasing Hormone in the Paraventricular Nucleus of the Hypothalamus- Beyond Hypothalamic-Pituitary-Adrenal Axis Control -- Chapter 10. Multifactorial Regulation of the Activity of Hypophysiotropic Thyrotropin-Releasing Hormone Neurons -- PART III. Hypothalamic Control of Neuroendocrine Functions -- Chapter 11. Circadian Control of Neuroendocrine Systems -- Chapter 12. The Neuroanatomical Organization of Hypothalamic Feeding Circuits -- Chapter 13. Melanin-Concentrating Hormone, Neuropeptide E-I, and MCH Receptor 1 -- Chapter 14. Neuroanatomy of Tuberoinfundibular Peptide 39 Related to Neuroendocrine and Behavioral Regulations -- Chapter 15. Functional Chemoanatomy of PACAP in Neuroendocrine and Neuronal Circuits -- Chapter 16. Functional Neuroanatomy of Relaxin-3/RXFP3 Systems in the Brain: Implications for Integrated Neuroendocrine and Behavioural Control.

Description / Table of Contents: The Purinergic Signaling: Overview -- Adenosine A2A Receptor-containing Heteromers and Neuroprotection -- Purinergic Signaling in Brain Physiology -- Neurotrophic Actions of Adenosine and Guanosine: Implications for Neural Development and Regeneration? -- Purinergic Signaling in Neurogenesis and Neural Fate Determination: Current Knowledge and Future Challenges -- Purinergic Signaling in Autism Spectrum Disorder -- Purinergic Signaling in Depression -- Roles of Purinergic Receptors in Alzheimer's Disease -- Purinergic Signaling in Basal Ganglia Diseases: Parkinson's Disease -- A Step in the ALS Direction: Lessons from the Purinome -- Purinergic P2 Receptors in Epilepsy -- Purinergic Signaling in Neuroinflammation -- Purinergic Signaling in Brain Tumors -- Development of Purinergic Receptor Agonists and Antagonists -- Acupuncture for Counteracting P2X4 and P2X7 Receptor Involvement in Neuroinflammation.

Description / Table of Contents: Epidemiology of tinnitus -- Genetics and tinnitus -- Pharmacological modelling of tinnitus in animals -- Animal models of sensory and brain stimulation effects on tinnitus -- Cochlear damage and the mechanisms of tinnitus - implications for treatments -- Functional neuroanatomy of tinnitus -- Neuroinflammation and tinnitus -- Using big data to guide therapy development -- Pharmacoltherapy for tinnitus -- Sound therapy devices and mechanisms -- Cochlear electrical stimulation -- Brain stimulation -- Biomodal stimulation -- Effect of tinnitus on attention and cognition -- Neurobiology of stress induced tinnitus -- Behavioral correlates of tinnitus -- Psychological aprroaches to tinnitus management -- Momentary evaluation -- Questionnaires -- Psychoacoustic evaluation of tinnitus.